A randomized, single-blind, pharmacokinetic and doseresponse study of subcutaneous methotrexate, 15 and 25 mg/week, for refractory ulcerative colitis and Crohn's disease

✍ Scribed by Egan, LJ; Sandborn, WJ; Tremaine, WJ; Leighton, JA; Mays, DC; Pike, MG; Zinsmeister, AR; Lipsky, JJ

• Book ID: 122053656
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 353 KB
• Volume: 114
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(98)83952-8